Verve Therapeutics Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Millions HKD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	18	21	18	19	32	36	Upgrade
Market Cap Growth	15.22%	15.22%	-2.13%	-40.51%	-11.24%	-88.88%	Upgrade
Enterprise Value	39	40	30	27	36	35	Upgrade
Last Close Price	0.44	0.53	0.46	0.47	0.79	0.89	Upgrade
PS Ratio	0.32	0.38	0.27	0.28	0.14	0.15	Upgrade
PB Ratio	-1.90	-2.28	0.63	0.47	0.61	0.65	Upgrade
P/TBV Ratio	-	-	0.76	0.47	0.61	0.65	Upgrade
P/FCF Ratio	-	-	25.24	237.98	-	64.85	Upgrade
P/OCF Ratio	-	-	25.24	237.98	-	9.82	Upgrade
EV/Sales Ratio	0.70	0.72	0.44	0.40	0.16	0.14	Upgrade
EV/FCF Ratio	-3.57	-	41.59	343.66	-	63.62	Upgrade
Debt / Equity Ratio	-2.57	-2.57	0.41	0.31	0.21	0.04	Upgrade
Debt / EBITDA Ratio	-	-	-	-	36.46	-	Upgrade
Debt / FCF Ratio	-	-	16.63	154.24	-	3.62	Upgrade
Asset Turnover	1.27	1.27	1.27	1.04	3.38	3.62	Upgrade
Quick Ratio	0.73	0.73	1.84	2.57	3.14	5.62	Upgrade
Current Ratio	0.79	0.79	1.95	2.64	3.16	5.86	Upgrade
Return on Equity (ROE)	-385.38%	-385.38%	-30.79%	-26.24%	-5.85%	-12.74%	Upgrade
Return on Assets (ROA)	-49.29%	-49.29%	-11.86%	-11.76%	-2.53%	-8.73%	Upgrade
Return on Capital (ROIC)	-76.88%	-76.88%	-13.74%	-13.29%	-2.88%	-9.61%	Upgrade
Earnings Yield	-219.16%	-181.95%	-57.95%	-64.18%	-9.92%	-21.08%	Upgrade
FCF Yield	-61.40%	-50.97%	3.96%	0.42%	-22.86%	1.54%	Upgrade

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.